Lv6
2590 积分 2024-05-31 加入
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
2个月前
已完结
Treatment strategies for advanced synovial sarcoma: from chemotherapy to TCR-engineered T-cell therapy
2个月前
已完结
Structures of butyrophilin multimers reveal a plier-like mechanism for Vγ9Vδ2 T cell receptor activation
3个月前
已完结
Multi-engineered T cell vaccine boosting TCR-T cell therapy enhances anti-tumor function and eradicates heterogeneous solid tumors
4个月前
已完结
Identification of MAGE-A10 specific T cell receptor promising in immunotherapy of hepatocellular carcinoma
5个月前
已完结
Spatio-temporal T cell tracking for personalized TCR-T designs in childhood cancer
5个月前
已关闭
miR-143-3p Promotes TSCM Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1
6个月前
已完结
Features of HLA‐A*02 in Identifying Eligible Patients for Tecelra TCR‐T Therapy
6个月前
已完结
Harnessing the Power of TCR-T Cell Therapy: A New Era in Cancer Immunotherapy
8个月前
已完结
Neoantigen-specific TCR-T cell therapy in advanced pancreatic cancer: a phase I clinical trial
8个月前
已关闭
皖公网安备34019202002308
